186 related articles for article (PubMed ID: 15361189)
1. Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma.
Raspollini MR; Amunni G; Villanucci A; Baroni G; Boddi V; Taddei GL
Int J Gynecol Cancer; 2004; 14(5):815-23. PubMed ID: 15361189
[TBL] [Abstract][Full Text] [Related]
2. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
[TBL] [Abstract][Full Text] [Related]
3. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
Crasta JA; Mishra S; Vallikad E
Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
[TBL] [Abstract][Full Text] [Related]
4. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.
Hartenbach EM; Olson TA; Goswitz JJ; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
Cancer Lett; 1997 Dec; 121(2):169-75. PubMed ID: 9570355
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of P-glycoprotein and proliferative index in advanced low grade serous ovarian carcinomas.
Raspollini MR; Amunni G; Villanucci A; Baroni G; Boddi V; Taddei GL
J Chemother; 2003 Aug; 15(4):380-6. PubMed ID: 12962367
[TBL] [Abstract][Full Text] [Related]
7. FGF18 as a potential biomarker in serous and mucinous ovarian tumors.
El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA
Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma.
Karavasilis V; Malamou-Mitsi V; Briasoulis E; Tsanou E; Kitsou E; Pavlidis N
Int J Gynecol Cancer; 2006; 16 Suppl 1():241-6. PubMed ID: 16515598
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
[TBL] [Abstract][Full Text] [Related]
10. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
Shi L; Chen XM; Wang L; Zhang L; Chen Z
Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
[TBL] [Abstract][Full Text] [Related]
11. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
12. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
[TBL] [Abstract][Full Text] [Related]
13. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
14. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
Gynecol Oncol; 2004 Mar; 92(3):806-12. PubMed ID: 14984945
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater.
Chen L; Tao SF; Zheng YX
Hepatogastroenterology; 2006; 53(67):45-50. PubMed ID: 16506374
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor.
Sönmezer M; Güngör M; Ensari A; Ortaç F
Int J Gynecol Cancer; 2004; 14(1):82-8. PubMed ID: 14764033
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor expression in early stage ovarian carcinoma.
Paley PJ; Staskus KA; Gebhard K; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
Cancer; 1997 Jul; 80(1):98-106. PubMed ID: 9210714
[TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis in advanced stage ovarian carcinoma.
Hollingsworth HC; Kohn EC; Steinberg SM; Rothenberg ML; Merino MJ
Am J Pathol; 1995 Jul; 147(1):33-41. PubMed ID: 7541612
[TBL] [Abstract][Full Text] [Related]
19. Correlation of epidermal growth factor receptor expression with tumor microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma.
Raspollini MR; Castiglione F; Garbini F; Villanucci A; Amunni G; Baroni G; Boddi V; Taddei GL
Int J Surg Pathol; 2005 Apr; 13(2):135-42. PubMed ID: 15864375
[TBL] [Abstract][Full Text] [Related]
20. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
